Cancer Gene Therapy - Table of Contents alert Volume 23 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 23, Issue 8 (August 2016) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you tried listening to the Genepod, the podcast from Genetics in Medicine? Hear direct from the experts, wherever you are and on whatever device. Past topics have included: Investigating the lower risk of solid tumors in Down Syndrome New and Old Quandaries in Newborn Screening Time and effort to practice medical genetics: an expanding challenge Listen to the Genepod and expand your genetics knowledge for free! Original Articles Top Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells OPEN R Schreiber, R Mezencev, L V Matyunina and J F McDonald Cancer Gene Ther 2016 23: 241-245; advance online publication, May 27, 2016; 10.1038/cgt.2016.23 Abstract | Full Text Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach R Nedaeinia, M Sharifi, A Avan, M Kazemi, L Rafiee, M Ghayour-Mobarhan and R Salehi Cancer Gene Ther 2016 23: 246-253; advance online publication, July 1, 2016; 10.1038/cgt.2016.25 Abstract | Full Text Antiproliferative effect of a synthetic aptamer mimicking androgen response elements in the LNCaP cell line S Kouhpayeh, A R Einizadeh, Z Hejazi, M Boshtam, L Shariati, M Mirian, L Darzi, M Sojoudi, H Khanahmad and A Rezaei Cancer Gene Ther 2016 23: 254-257; advance online publication, July 1, 2016; 10.1038/cgt.2016.26 Abstract | Full Text MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer L Tang, D Wei and F Yan Cancer Gene Ther 2016 23: 258-265; advance online publication, July 1, 2016; 10.1038/cgt.2016.27 Abstract | Full Text Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1 K Hasegawa, M Tagawa, K Takagi, H Tsukamoto, Y Tomioka, T Suzuki, Y Nishioka, T Ohrui and M Numasaki Cancer Gene Ther 2016 23: 266-277; advance online publication, August 19, 2016; 10.1038/cgt.2016.29 Abstract | Full Text Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer H Sawahara, H Shiraha, D Uchida, H Kato, T Nagahara, M Iwamuro, J Kataoka, S Horiguchi, M Watanabe, M Sakaguchi, A Takaki, K Nouso, Y Nasu, H Kumon and H Okada Cancer Gene Ther 2016 23: 278-283; advance online publication, July 29, 2016; 10.1038/cgt.2016.31 Abstract | Full Text Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.